Masateru Miyake

1.4k total citations
39 papers, 1.1k citations indexed

About

Masateru Miyake is a scholar working on Pharmaceutical Science, Oncology and Molecular Biology. According to data from OpenAlex, Masateru Miyake has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 12 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Masateru Miyake's work include Drug Transport and Resistance Mechanisms (12 papers), Drug Solubulity and Delivery Systems (8 papers) and Advanced Drug Delivery Systems (8 papers). Masateru Miyake is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Drug Solubulity and Delivery Systems (8 papers) and Advanced Drug Delivery Systems (8 papers). Masateru Miyake collaborates with scholars based in Japan, Sweden and United States. Masateru Miyake's co-authors include Kazutaka Higaki, Hajime Toguchi, Toshikiro Kimura, Masaaki Odomi, T. Mukai, Naoki Kamada, Keigo Yamada, Gary G. Liversidge, Ken‐ichi Ogawara and Daisuke Nakai and has published in prestigious journals such as Journal of Controlled Release, British Journal of Cancer and International Journal of Pharmaceutics.

In The Last Decade

Masateru Miyake

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masateru Miyake Japan 16 567 240 212 177 101 39 1.1k
Bhagwant Rege United States 9 509 0.9× 244 1.0× 136 0.6× 275 1.6× 36 0.4× 12 948
Rajesh Gandhi United States 15 563 1.0× 296 1.2× 472 2.2× 128 0.7× 36 0.4× 26 1.3k
Dallas B. Warren Australia 17 558 1.0× 277 1.2× 295 1.4× 136 0.8× 29 0.3× 29 1.1k
Rodrigo Cristofoletti United States 19 508 0.9× 218 0.9× 195 0.9× 124 0.7× 38 0.4× 88 1.1k
Avital Beig Israel 20 1.2k 2.1× 290 1.2× 428 2.0× 458 2.6× 62 0.6× 29 1.7k
Neelam Seedher India 13 286 0.5× 368 1.5× 248 1.2× 203 1.1× 22 0.2× 34 931
Robert A. Carr United States 19 338 0.6× 193 0.8× 156 0.7× 191 1.1× 72 0.7× 41 986
Krishnaswamy Raghavan United States 15 447 0.8× 222 0.9× 594 2.8× 121 0.7× 36 0.4× 26 1.4k
Amale Hawi United States 11 287 0.5× 247 1.0× 133 0.6× 163 0.9× 98 1.0× 26 1.0k
Kimberley A. Lentz United States 14 323 0.6× 199 0.8× 136 0.6× 305 1.7× 33 0.3× 24 963

Countries citing papers authored by Masateru Miyake

Since Specialization
Citations

This map shows the geographic impact of Masateru Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masateru Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masateru Miyake more than expected).

Fields of papers citing papers by Masateru Miyake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masateru Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masateru Miyake. The network helps show where Masateru Miyake may publish in the future.

Co-authorship network of co-authors of Masateru Miyake

This figure shows the co-authorship network connecting the top 25 collaborators of Masateru Miyake. A scholar is included among the top collaborators of Masateru Miyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masateru Miyake. Masateru Miyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruyama, Masato, Yohei Nishida, Hironori Tanaka, et al.. (2022). Analysis of absorption-enhancing mechanisms for combinatorial use of spermine with sodium taurocholate in Caco-2 cells. European Journal of Pharmaceutics and Biopharmaceutics. 180. 332–343. 8 indexed citations
2.
Nakai, Daisuke & Masateru Miyake. (2022). The change of the electrophysiological parameters using human intestinal tissues from ulcerative colitis and Crohn's disease. Journal of Pharmacological Sciences. 150(2). 90–93. 4 indexed citations
3.
Miyake, Masateru, et al.. (2021). Spermine with Sodium Taurocholate Enhances Pulmonary Absorption of Macromolecules in Rats. Journal of Pharmaceutical Sciences. 110(10). 3464–3470. 2 indexed citations
4.
Mochizuki, Toshio, et al.. (2021). Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance. Clinical and Experimental Nephrology. 25(11). 1231–1239. 13 indexed citations
5.
Miyake, Masateru, Yoshikazu Oka, & T. Mukai. (2019). Food effect on meal administration time of pharmacokinetic profile of cilostazol, a BCS class II drug. Xenobiotica. 50(2). 232–236. 3 indexed citations
6.
Nakai, Daisuke, Masateru Miyake, & Ayako Hashimoto. (2019). Comparison of the Intestinal Drug Permeation and Accumulation Between Normal Human Intestinal Tissues and Human Intestinal Tissues With Ulcerative Colitis. Journal of Pharmaceutical Sciences. 109(4). 1623–1626. 10 indexed citations
7.
Kondo, Satoshi & Masateru Miyake. (2018). Simultaneous Prediction of Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber System. Journal of Pharmaceutical Sciences. 108(1). 763–769. 10 indexed citations
8.
Miyake, Masateru, Satoshi Kondo, Toshihisa Koga, et al.. (2017). Evaluation of intestinal metabolism and absorption using the Ussing chamber system equipped with intestinal tissue from rats and dogs. European Journal of Pharmaceutics and Biopharmaceutics. 122. 49–53. 13 indexed citations
9.
Miyake, Masateru, et al.. (2017). Arachidonic acid with taurine enhances pulmonary absorption of macromolecules without any serious histopathological damages. European Journal of Pharmaceutics and Biopharmaceutics. 114. 22–28. 5 indexed citations
10.
Miyake, Masateru, Toshihisa Koga, Satoshi Kondo, et al.. (2016). Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans. European Journal of Pharmaceutical Sciences. 96. 373–380. 37 indexed citations
11.
Emoto, Chie, Shoichi Date, Satoshi Kondo, et al.. (2012). Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes. Xenobiotica. 42(8). 719–730. 8 indexed citations
12.
Yamazaki, Hiroshi, Masateru Miyake, Naoki Kamada, et al.. (2010). Co-administration of Tacrolimus Suppresses Pharmacokinetic Modulation of Multiple Subcutaneously Administered Human Interferon-alpha in Beagle Dogs. Drug Metabolism and Pharmacokinetics. 25(2). 149–154. 3 indexed citations
13.
Yamazaki, Hiroshi, Masateru Miyake, T. Mukai, et al.. (2009). Effect of Co-administration of Tacrolimus on the Pharmacokinetics of Multiple Subcutaneous Administered Interferon-Alpha in Rats. Pharmaceutical Research. 26(8). 1832–1837. 1 indexed citations
14.
Kamada, Naoki, Masateru Miyake, Keigo Yamada, et al.. (2008). In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. Journal of Controlled Release. 130(1). 29–37. 58 indexed citations
15.
Miyake, Masateru, Hajime Toguchi, Masaaki Odomi, et al.. (2006). Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. Journal of Controlled Release. 115(2). 130–133. 20 indexed citations
16.
Miyake, Masateru, Masao Hirota, Hajime Toguchi, et al.. (2006). Novel oral formulation safely improving intestinal absorption of poorly absorbable drugs: Utilization of polyamines and bile acids. Journal of Controlled Release. 111(1-2). 27–34. 36 indexed citations
17.
Miyake, Masateru, Naoki Kamada, Yoshikazu Oka, et al.. (2004). Development of suppository formulation safely improving rectal absorption of rebamipide, a poorly absorbable drug, by utilizing sodium laurate and taurine. Journal of Controlled Release. 99(1). 63–71. 21 indexed citations
18.
Endo, Yoko, et al.. (2002). Mechanisms of cytoprotective effect of amino acids on local toxicity caused by sodium laurate, a drug absorption enhancer, in intestinal epithelium. Journal of Pharmaceutical Sciences. 91(3). 730–743. 22 indexed citations
19.
Ito, Hideyuki, Masateru Miyake, Kazuko Mori, et al.. (1999). Anti-tumor promoting activity of polyphenols from Cowania mexicana and Coleogyne ramosissima. Cancer Letters. 143(1). 5–13. 72 indexed citations
20.
Nakano, Takashi, et al.. (1998). Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. British Journal of Cancer. 77(6). 907–912. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhagwant Rege Breakdown of academic impact, for papers by Rajesh Gandhi Breakdown of academic impact, for papers by Dallas B. Warren Breakdown of academic impact, for papers by Rodrigo Cristofoletti Breakdown of academic impact, for papers by Avital Beig Breakdown of academic impact, for papers by Neelam Seedher Breakdown of academic impact, for papers by Robert A. Carr Breakdown of academic impact, for papers by Krishnaswamy Raghavan Breakdown of academic impact, for papers by Amale Hawi Breakdown of academic impact, for papers by Kimberley A. Lentz
Rankless by CCL
2026